Metastatic Melanoma, BRAF V600 Mutation Positive

Explore clinical trials studying Metastatic Melanoma, BRAF V600 Mutation Positive. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Melanoma, BRAF V600 Mutation Positive trial results

Completed

NCT02608034

Conditions: Melanoma, Metastatic Melanoma, BRAF V600 Mutation Positive, Neoplasms, +10 more
Locations: Mary Crowley Medical Research Center Dallas, Texas, United States

Rambam Health Care Campus; Oncology Haifa, Israel

Hadassah Ein Karem Hospital; Oncology Dept Jerusalem, Israel

Tel Aviv Sourasky Medical Center; Pharmacy Tel Aviv, Israel

Active, Not Recruiting

NCT07022457

Conditions: Melanoma, Metastatic Melanoma, BRAF V600 Mutation Positive, Neoplasms, +10 more
Locations: Southend University Hospital Westcliff-on-Sea, Essex, United Kingdom

Queen Elizabeth Hospital Birmingham, United Kingdom

Addenbrookes Hospital Cambridge, United Kingdom

University Hospital Coventry and Warwickshire Coventry, United Kingdom